Floatz logo

Autologous Cd1C+ /Cd141+ Mydc

Metastases to Soft Tissue

Universitair Ziekenhuis BrusselCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Metastases to Soft Tissue cohort.

Asset / SponsorPhaseRating
Nivolumab
Mohammed Milhem
Phase 2B
AS01b
Universitair Ziekenhuis Brussel
Phase 1/2CCC

Same molecule, other indications

Autologous Cd1C+ /Cd141+ Mydc is also rated in:

neoplasmDormant
CCC
Indicative ·
50 / 100
View asset →
non-small cell lung carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
glioblastomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →